Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanoma
about
Immunological effect of local ablation combined with immunotherapy on solid malignancies.Amelioration of Inflammatory Cytokines Mix Stimulation: A Pretreatment of CD137 Signaling Study on VSMC.CD137-CD137L interaction modulates neointima formation and the phenotype transformation of vascular smooth muscle cells via NFATc1 signaling.4-1BB (CD137) and radiation therapy: A case report and literature review.Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination.
P2860
Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanoma
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Concomitant targeting of progr ...... human BRAFV600-mutant melanoma
@en
type
label
Concomitant targeting of progr ...... human BRAFV600-mutant melanoma
@en
prefLabel
Concomitant targeting of progr ...... human BRAFV600-mutant melanoma
@en
P2093
P2860
P1476
Concomitant targeting of progr ...... human BRAFV600-mutant melanoma
@en
P2093
Christian U Blank
Hideo Yagita
Inge Verbrugge
Jannie Borst
Jules Gadiot
Marcel A Deken
Marcel Verheij
Paula Kroon
P2860
P2888
P304
P356
10.1007/S00262-016-1843-4
P577
2016-05-09T00:00:00Z